How Many Vaccine Sciences Are There?

Via Blue State Conservative

The FDA gave clearance to children being vaccinated with a novel mRNA cocktail against a disease which they have higher than a 99.997% chance of survival. Keep in mind, that figure isn’t 100% because children with mostly severe underlying health conditions succumbed with the presence of the virus in their system. It’s no less tragic, but these are the facts.

To sum up the advisory board’s authorization, children already aren’t vectors of transmission and are not at risk of the virus, but now they will get experimental poison injected into their minimal musculature that still doesn’t prevent transmission, still doesn’t offer any more protection than before, carries extreme risks, and has unknowable long-term side effects. That’s some science.

Continue reading “How Many Vaccine Sciences Are There?”

For the public record: Critical questions FDA must address about vaccine safety

Guest Post by Steve Kirsch

For the public record: Critical questions FDA must address about vaccine safety

On October 26, I was invited by the FDA to give a 3-minute slide presentation during the Open Public Hearing session at the meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) which is the outside committee of the FDA that reviews vaccine safety and efficacy.

Today’s meeting is focused on whether or not to extend the EUA of the Pfizer vaccines for children aged 5 to 11.

Continue reading “For the public record: Critical questions FDA must address about vaccine safety”

‘This Is Politics, Not Science’: White House, CDC Prepare to Vaccinate 5- to 11-Year-Olds Prior to FDA Authorization

Via Children’s Health Defense

The White House today unveiled plans to roll out COVID vaccines for children ages 5 to 11.

The White House today unveiled plans to roll out COVID vaccines for children ages 5 to 11, even though vaccine safety experts — who advise U.S. drug regulators and review safety and efficacy data — have not met to discuss whether Pfizer’s COVID vaccine should be authorized for use in the pediatric age group.

The Biden administration said it will secure enough vaccine doses to vaccinate the 28 million children ages 5 to 11 who would become eligible if the vaccine is authorized for that age group, CNN reported.

The White House will also help equip more than 25,000 pediatric and primary care offices, hundreds of community health centers and rural health clinics as well as tens of thousands of pharmacies to administer the shot.

Continue reading “‘This Is Politics, Not Science’: White House, CDC Prepare to Vaccinate 5- to 11-Year-Olds Prior to FDA Authorization”